NCT01214174View on ClinicalTrials.gov

Efficacy and Safety Study of IBI-10090 in Cataract Surgery Patients

PHASE2TerminatedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Ocular Inflammation
Interventions
DRUG

IBI-10090

Trial Locations (1)

97401

Drs. Fine, Hoffman, and Packer, Eugene

Sponsors
All Listed Sponsors
lead

ICON Bioscience Inc

INDUSTRY